“We aim to create an inspiring meeting where diabetes researchers can interact and form new collaborations,” says Hindrik Mulder, professor of metabolism at Lund University and chair of the organising committee.

The two-day event offers thematic sessions on diabetes research, such as human islets in diabetes research, cardiovascular complications in diabetes, diabetic kidney disease and precision medicine. 

“The meeting offers an exciting combination of sessions that we hope will be of interest to diabetes researchers in Sweden from different fields. One of our sessions will be dedicated to younger researchers, who will be given the opportunity to present their research to a wider audience,” says Hindrik Mulder.

Two internationally renowned diabetes researchers have been invited to give keynote lectures. Bruce Spiegelman, professor of cell biology and medicine at Harvard University, will give a lecture on biochemical pathways and therapeutic opportunities in relation to adipose cells and diabetes. Jens Juul Holst, professor at the Department of Biomedical Sciences at University of Copenhagen, will hold a lecture about the role of glucagon in diabetes.

“An important objective of these meetings is to expose the Swedish research community to world-leading research. Bruce Spiegelman and Jens Juul Holst are two world-renowned researchers that have made significant contributions to diabetes research,” says Hindrik Mulder.

The Swedish diabetes summits are organised by the two Swedish strategic research areas within diabetes. EXODIAB (Excellence of diabetes research in Sweden), a strategic research collaboration between Lund University and Uppsala University, is the main organiser of the summit which will be held as an online meeting over Zoom the 10th and 11th of February. 

SRP Diabetes (Strategic research programme in Diabetes) is co-organiser. This strategic research area is a collaboration between Karolinska Institutet and Umeå University.

It is free of charge to participate.